Verified Clinical Trials Exhibits at the Annual 2014 DIA Meeting to Discuss the Research Subject Clinical Trial Database Registry and the Tools to Stop Dual Enrollment

Verified Clinical Trials is proud to announce their presence at the 2014 Annual DIA meeting in San Diego, California. Verified Clinical Trials will discuss the largest North American clinical research volunteer database that stops dual enrollment in clinical trials, while promoting patient safety and data quality.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Verified Clinical Trials
The use cases for this technology are endless and range from providing instant safety information, study related instructions, and empowering research subjects with information regarding the study they were enrolled in

Garden City, New York (PRWEB) April 21, 2014

Verified Clinical Trials (VCT) will again be an exhibitor at the the 2014 Annual DIA Meeting in San Diego. While at the conference, Verified Clinical Trials will demonstrate the sophisticated system that it has developed to stop potential professional research subjects from dual enrolling in multiple clinical trials.

Mitchell Efros MD FACS, CEO of Verified Clinical Trials (VCT), will describe methods to detect professional research subjects and dual enrollment in clinical trials by use of the unified global research subject clinical trial database registry that VCT offers as a means to discover these individuals and improve clinical trial research subject safety and data quality. Verified Clinical Trials (VCT) is the largest North American research subject clinical trials database registry . Because VCT is 100% web based, the system is scalable and affordable without the need to purchase and install software or hardware. This allows VCT to focus on both early phase and late phase trials improving the coverage and worth of the entire database. Coverage with the VCT database system includes large research facilities and thousands of smaller sites involved in later phase trials as well.

Dr. Mitchell Efros, plans to review many of the added features that VCT now offers including the “Direct Connect Program” that allows Sponsors to directly reach their study participants in a de-identified manner.

“The use cases for this technology are endless and range from providing instant safety information, study related instructions, and empowering research subjects with information regarding the study they were enrolled in” stated Dr. Efros. These value added features improve safety, data quality, and compliance.

Verified Clinical Trials also offers a new Compliance and Protocol Deviation Monitor to provide instant access to these events across one or all of the studies a particular Sponsor or CRO is conducting.

About Verified Clinical Trials:
Verified Clinical Trials was developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world’s leader in the field of clinical trial database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities. To RSVP or for more information, visit http://www.verifiedclinicaltrials.com.